Efficacy and safety of tocilizumab in COVID-19 patients
Research Paper
[키워드] A significant reduction
addition
Adverse drug reactions
analyzed
C-reactive protein
changes in
clinical manifestations
Clinical outcome
clinical trial
cough
COVID-19
COVID-19 patient
Critical
CT scan
Cytokine storm
effective
Efficacy and safety
enrolled
Fever
Huoshenshan Hospital
IL-6
IMPROVE
in some
interleukin-6
Laboratory test
Patient
reported
Retrospective study
SARS-CoV-2
severe coronavirus disease
severe COVID-19
Shortness of breath
therapeutic strategy
Tocilizumab
tocilizumab administration
treated
Treatment
Wuhan, China
[DOI] 10.18632/aging.103988 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.18632/aging.103988 PMC 바로가기 [Article Type] Research Paper